David L. Szekeres
David Szekeres' Bio
David L. Szekeres has served on the Sanford Burnham Prebys Board of Trustees since 2019.
He is executive vice president and chief operating officer of Heron Therapeutics, a San Diego-based biotechnology company developing best-in-class treatments in oncology and pain.
Previously, Szekeres had been chief business officer, principal financial officer and general counsel at Regulus Therapeutics; head of Mergers & Acquisitions at Life Technologies Corporation; a corporate attorney at Latham & Watkins; and a senior associate in investment banking at Robertson Stephens.
Szekeres serves as chairman of the board of GRI Bio, a clinical-stage biopharmaceutical company focused on inflammatory and autoimmune disease treatment; and an executive advisory board member at Colossal Biosciences, a biotechnology and genetic engineering company working to genetically resurrect extinct animal species.
He is also a board member of CureMatch, a software company focused on personalized medicine and combination therapy in oncology; and chairman of the board of Animantis, a software company focused on automated, cloud-based, artificial intelligence applications to improve drug discovery and development.
He has a Bachelor of Arts degree in criminology, law and society from the University of California Irvine and a Juris Doctor degree from Duke University School of Law.